Emerging Novel Enzyme Pathways in Drug Metabolism Prevalence of Non – Cytochrome P 450 – Mediated Metabolism in Food and Drug Administration – Approved Oral and Intravenous Drugs : 2006 – 2015 s

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Xenobiotica the fate of foreign compounds in biological systems

  2017cited by this paper
• Metabolism and metabolite profiles in vitro and in vivo of ospemifene in humans and preclinical species

  2016cited by this paper
• Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.

  2016cited by this paper
• Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions—an Industry Perspective

  2016cited by this paper
• Identification of Human Sulfotransferases Involved in Lorcaserin N-Sulfamate Formation

  2016cited by this paper
• Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans

  2016cited by this paper
• Innovation in the pharmaceutical industry: New estimates of R&D costs.

  2016cited by this paper
• Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

  2016cited by this paper
• Human Sulfotransferases Enhance the Cytotoxicity of Tolvaptan.

  2016cited by this paper
• Pharmacokinetics: metabolism and excretion

  2015cited by this paper
• Reaction Phenotyping: Advances in the Experimental Strategies Used to Characterize the Contribution of Drug-Metabolizing Enzymes

  2015cited by this paper
• Metabolism of Xenobiotics by Aldehyde Oxidase

  2015cited by this paper
• Carboxylesterase 1-mediated drug-drug interactions between clopidogrel and simvastatin.

  2015cited by this paper
• Sex-, Species-, and Tissue-Specific Metabolism of Empagliflozin in Male Mouse Kidney Forms an Unstable Hemiacetal Metabolite (M466/2) That Degrades to 4-Hydroxycrotonaldehyde, a Reactive and Cytotoxic Species.

  2015cited by this paper
• The aldo-keto reductases (AKRs): Overview.

  2015cited by this paper
• In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans

  2015cited by this paper
• A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma

  2015cited by this paper
• Inhibition of SN-38 glucuronidation by gefitinib and its metabolite

  2015influential reference
• Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects.

  2015cited by this paper
• A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development.

  2015influential reference
• The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation

  2015cited by this paper
• A Novel Reaction Mediated by Human Aldehyde Oxidase: Amide Hydrolysis of GDC-0834

  2015cited by this paper
• Nintedanib: from discovery to the clinic.

  2015cited by this paper
• Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers

  2015cited by this paper
• Chemistry-enabled drug delivery (prodrugs): recent progress and challenges.

  2014cited by this paper
• Hepatic Microsomal Thiol Methyltransferase Is Involved in Stereoselective Methylation of Pharmacologically Active Metabolite of Prasugrel

  2014cited by this paper
• Pharmacokinetics, Metabolism, and Excretion of [14C]Axitinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Humans

  2014cited by this paper
• The metabolic drug-drug interaction profile of dabrafenib: In vitro investigations and quantitative extrapolation of the P450-mediated DDI risk

  2014cited by this paper
• Aldehyde Oxidase Activity in Donor-Matched Fresh and Cryopreserved Human Hepatocytes and Assessment of Variability in 75 Donors

  2014cited by this paper
• Impact of Endogenous Esterase Activity on In Vitro P-Glycoprotein Profiling of Dabigatran Etexilate in Caco-2 Monolayers

  2014cited by this paper
• Metabolism and Antiretroviral Activity of Tenofovir Alafenamide in CD4+ T-Cells and Macrophages from Demographically Diverse Donors

  2014cited by this paper
• The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans

  2014cited by this paper
• Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers

  2014cited by this paper
• Determination of regorafenib (BAY 73-4506) and its major human metabolites BAY 75-7495 (M-2) and BAY 81-8752 (M-5) in human plasma by stable-isotope dilution liquid chromatography-tandem mass spectrometry.

  2014cited by this paper
• Evaluation of the potency of telaprevir and its metabolites as inhibitors of renal organic cation transporters, a potential mechanism for the elevation of serum creatinine.

  2014cited by this paper
• Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drug

  2014cited by this paper
• Cynomolgus Monkey as a Surrogate for Human Aldehyde Oxidase Metabolism of the EGFR Inhibitor BIBX1382

  2014cited by this paper
• Assessment of the Mass Balance Recovery and Metabolite Profile of Avibactam in Humans and In Vitro Drug-Drug Interaction Potential

  2014cited by this paper
• Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches.

  2014cited by this paper
• Bioavailability, metabolism and disposition of oral pazopanib in patients with advanced cancer

  2013cited by this paper
• Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

  2013cited by this paper
• Metabolic Disposition of [14C] Ulipristal Acetate in Healthy Premenopausal Women

  2013cited by this paper
• Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

  2013cited by this paper
• Human Biotransformation of the Nonnucleoside Reverse Transcriptase Inhibitor Rilpivirine and a Cross-Species Metabolism Comparison

  2013cited by this paper
• Ospemifene metabolism in humans in vitro and in vivo: metabolite identification, quantitation, and CYP assignment of major hydroxylations

  2013cited by this paper
• Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

  2013cited by this paper
• Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma

  2013cited by this paper
• Identification of metabolites of dalfampridine (4-aminopyridine) in human subjects and reaction phenotyping of relevant cytochrome P450 pathways

  2013cited by this paper
• Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.

  2013cited by this paper
• Metabolism-Dependent Inhibition of CYP3A4 by Lapatinib: Evidence for Formation of a Metabolic Intermediate Complex with a Nitroso/Oxime Metabolite Formed via a Nitrone Intermediate

  2013cited by this paper
• Strategies for a comprehensive understanding of metabolism by aldehyde oxidase

  2013cited by this paper
• Netupitant PET imaging and ADME studies in humans

  2013cited by this paper
• Biotransformation of the Antiretroviral Drug Etravirine: Metabolite Identification, Reaction Phenotyping, and Characterization of Autoinduction of Cytochrome P450-Dependent Metabolism

  2012cited by this paper
• Characterization of Aldehyde Oxidase Enzyme Activity in Cryopreserved Human Hepatocytes

  2012cited by this paper
• Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers

  2012cited by this paper
• Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application

  2012cited by this paper
• Human Metabolism of Lapatinib, a Dual Kinase Inhibitor: Implications for Hepatotoxicity

  2012cited by this paper
• Identification of Human Cytochrome P450 and Flavin-Containing Monooxygenase Enzymes Involved in the Metabolism of Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine 2C Agonist

  2012cited by this paper
• Absorption, disposition, metabolic fate and elimination of the anti-epileptic drug lacosamide in humans: mass balance following intravenous and oral administration

  2012cited by this paper
• Bioactivation by Phase‐II‐Enzyme‐Catalyzed Conjugation of Xenobiotics

  2012cited by this paper
• Pharmacokinetics, Biotransformation, and Mass Balance of Edoxaban, a Selective, Direct Factor Xa Inhibitor, in Humans

  2012cited by this paper
• Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled 14C material in advanced cancer patients

  2012cited by this paper
• Pharmacokinetics and drug interactions of eslicarbazepine acetate

  2012cited by this paper
• Identification of the Cytochrome P450 and Other Enzymes Involved in the In Vitro Oxidative Metabolism of a Novel Antidepressant, Lu AA21004

  2012cited by this paper
• Pharmacokinetics, Distribution, and Metabolism of [14C]Sunitinib in Rats, Monkeys, and Humans

  2012cited by this paper
• Excretion and Metabolism of Milnacipran in Humans after Oral Administration of Milnacipran Hydrochloride

  2012cited by this paper
• Radiolabeled absorption, distribution, metabolism, and excretion studies in drug development: why, when, and how?

  2012cited by this paper
• Biocatalytic Synthesis and Structure Elucidation of Cyclized Metabolites of the Deacetylase Inhibitor Panobinostat (LBH589)

  2012cited by this paper
• The pharmacological landscape and therapeutic potential of serine hydrolases

  2012cited by this paper
• The metabolic serine hydrolases and their functions in mammalian physiology and disease.

  2011cited by this paper
• Metabolic Intermediate Complex Formation of Human Cytochrome P450 3A4 by Lapatinib

  2011cited by this paper
• Identification of Human Liver Cytochrome P450 Enzymes Involved in the Metabolism of SCH 530348 (Vorapaxar), a Potent Oral Thrombin Protease-Activated Receptor 1 Antagonist

  2011cited by this paper
• Enzyme-mediated hydrolytic activation of prodrugs

  2011cited by this paper
• A Single Dose Mass Balance Study of the Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Humans Using Accelerator Mass Spectrometry

  2011cited by this paper
• Biosynthesis and Identification of an N-Oxide/N-Glucuronide Metabolite and First Synthesis of an N-O-Glucuronide Metabolite of Lu AA21004

  2011cited by this paper
• Investigation of the metabolism of rufinamide and its interaction with valproate.

  2011cited by this paper
• Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology

  2011cited by this paper
• Significant Species Difference in Amide Hydrolysis of GDC-0834, a Novel Potent and Selective Bruton's Tyrosine Kinase Inhibitor

  2011cited by this paper
• Bioactivation II: Phase I (Non-P450)

  2011cited by this paper
• Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir

  2011cited by this paper
• Metabolism Studies of Desvenlafaxine

  2011cited by this paper
• Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor

  2011cited by this paper
• CYP4F Enzymes Are Responsible for the Elimination of Fingolimod (FTY720), a Novel Treatment of Relapsing Multiple Sclerosis

  2011cited by this paper
• Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion

  2010cited by this paper
• Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

  2010cited by this paper
• In Vitro Metabolism, Permeability, and Efflux of Bazedoxifene in Humans

  2010cited by this paper
• Metabolism, Excretion, and Pharmacokinetics of [14C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans

  2010cited by this paper
• Uncovering the Human Methyltransferasome*

  2010cited by this paper
• Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977

  2010cited by this paper
• Species-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological Implications

  2010cited by this paper
• EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

  2010cited by this paper
• Aldehyde oxidase: an enzyme of emerging importance in drug discovery.

  2010influential reference
• Dabigatran Acylglucuronide, the Major Human Metabolite of Dabigatran: In Vitro Formation, Stability, and Pharmacological Activity

  2010cited by this paper
• Review of teriflunomide and its potential in the treatment of multiple sclerosis

  2009cited by this paper
• Quantitative Evaluation of the Expression and Activity of Five Major Sulfotransferases (SULTs) in Human Tissues: The SULT “Pie”

  2009cited by this paper
• Deferiprone Glucuronidation by Human Tissues and Recombinant UDP Glucuronosyltransferase 1A6: An in Vitro Investigation of Genetic and Splice Variants

  2009cited by this paper
• The Effect of Etoricoxib on the Pharmacokinetics of Oral Contraceptives in Healthy Participants

  2009cited by this paper
• Biotransformation profiling of [(14)C]ixabepilone in human plasma, urine and feces samples using accelerator mass spectrometry (AMS).

  2009cited by this paper
• Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans

  2009cited by this paper
• Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases.

  2009cited by this paper

• No citing papers are available for this paper.